1. Home
  2. ETNB vs CCB Comparison

ETNB vs CCB Comparison

Compare ETNB & CCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • CCB
  • Stock Information
  • Founded
  • ETNB 2018
  • CCB 1997
  • Country
  • ETNB United States
  • CCB United States
  • Employees
  • ETNB N/A
  • CCB N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • CCB Major Banks
  • Sector
  • ETNB Health Care
  • CCB Finance
  • Exchange
  • ETNB Nasdaq
  • CCB Nasdaq
  • Market Cap
  • ETNB 1.5B
  • CCB 1.3B
  • IPO Year
  • ETNB 2019
  • CCB 2018
  • Fundamental
  • Price
  • ETNB $10.12
  • CCB $102.62
  • Analyst Decision
  • ETNB Strong Buy
  • CCB Strong Buy
  • Analyst Count
  • ETNB 8
  • CCB 3
  • Target Price
  • ETNB $26.43
  • CCB $103.33
  • AVG Volume (30 Days)
  • ETNB 2.2M
  • CCB 136.9K
  • Earning Date
  • ETNB 08-04-2025
  • CCB 07-28-2025
  • Dividend Yield
  • ETNB N/A
  • CCB N/A
  • EPS Growth
  • ETNB N/A
  • CCB 17.53
  • EPS
  • ETNB N/A
  • CCB 3.36
  • Revenue
  • ETNB N/A
  • CCB $322,160,000.00
  • Revenue This Year
  • ETNB N/A
  • CCB $109.11
  • Revenue Next Year
  • ETNB N/A
  • CCB $36.30
  • P/E Ratio
  • ETNB N/A
  • CCB $30.53
  • Revenue Growth
  • ETNB N/A
  • CCB 25.44
  • 52 Week Low
  • ETNB $4.16
  • CCB $43.43
  • 52 Week High
  • ETNB $11.84
  • CCB $106.38
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 58.34
  • CCB 69.56
  • Support Level
  • ETNB $9.45
  • CCB $95.68
  • Resistance Level
  • ETNB $10.34
  • CCB $94.09
  • Average True Range (ATR)
  • ETNB 0.52
  • CCB 3.63
  • MACD
  • ETNB -0.07
  • CCB 1.52
  • Stochastic Oscillator
  • ETNB 69.34
  • CCB 85.19

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About CCB Coastal Financial Corporation

Coastal Financial Corp is a financial service provider. The company provides banking products and services to consumers and small to medium-sized businesses. Its business is conducted through three reportable segments: The community bank, CCBX, and treasury & administration. The primary focus of the community bank is on providing a wide range of banking products and services to consumers and small to medium-sized businesses in the broader Puget Sound region in the state of Washington and through the Internet and mobile banking applications.

Share on Social Networks: